Free Trial

Liquidia Technologies (LQDA) Stock Price, News & Analysis

Liquidia Technologies logo
$22.48 -0.70 (-3.02%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$22.75 +0.27 (+1.20%)
As of 10/17/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Liquidia Technologies Stock (NASDAQ:LQDA)

Advanced

Key Stats

Today's Range
$22.14
$23.23
50-Day Range
$21.20
$29.22
52-Week Range
$9.71
$29.94
Volume
1.92 million shs
Average Volume
3.00 million shs
Market Capitalization
$1.94 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.38
Consensus Rating
Moderate Buy

Company Overview

Liquidia Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

LQDA MarketRank™: 

Liquidia Technologies scored higher than 71% of companies evaluated by MarketBeat, and ranked 289th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Liquidia Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, no hold ratings, and 2 sell ratings.

  • Upside Potential

    Liquidia Technologies has a consensus price target of $32.38, representing about 44.0% upside from its current price of $22.48.

  • Amount of Analyst Coverage

    Liquidia Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Liquidia Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Liquidia Technologies are expected to grow in the coming year, from ($1.51) to ($1.32) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Liquidia Technologies is -13.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Liquidia Technologies is -13.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Liquidia Technologies has a P/B Ratio of 24.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Liquidia Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    21.36% of the outstanding shares of Liquidia Technologies have been sold short.
  • Short Interest Ratio / Days to Cover

    Liquidia Technologies has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Liquidia Technologies has recently decreased by 0.43%, indicating that investor sentiment is improving.
  • Dividend Yield

    Liquidia Technologies does not currently pay a dividend.

  • Dividend Growth

    Liquidia Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    21.36% of the outstanding shares of Liquidia Technologies have been sold short.
  • Short Interest Ratio / Days to Cover

    Liquidia Technologies has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in Liquidia Technologies has recently decreased by 0.43%, indicating that investor sentiment is improving.
  • News Sentiment

    Liquidia Technologies has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for Liquidia Technologies this week, compared to 7 articles on an average week.
  • Search Interest

    22 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 450% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Liquidia Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Liquidia Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,210,818.00 in company stock.

  • Percentage Held by Insiders

    26.50% of the stock of Liquidia Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    64.54% of the stock of Liquidia Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Liquidia Technologies' insider trading history.
Receive LQDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liquidia Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LQDA Stock News Headlines

Holy ****... This could actually MAGA
A new document circulating from Washington is stirring major controversy — one that some say could redefine America’s economic future. It details why tariffs, trade wars, and political unrest may all be part of a broader plan to trigger what insiders are calling the most significant wealth transfer in modern history. Whether you support it or not, this report could shape the financial landscape for years to come.tc pixel
Smart Money Is Betting Big In LQDA Options
See More Headlines

LQDA Stock Analysis - Frequently Asked Questions

Liquidia Technologies' stock was trading at $11.76 at the beginning of 2025. Since then, LQDA shares have increased by 91.2% and is now trading at $22.48.

Liquidia Technologies, Inc. (NASDAQ:LQDA) posted its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by $0.06. The firm's revenue was up 141.5% compared to the same quarter last year.
Read the conference call transcript
.

Liquidia Technologies (LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

Top institutional shareholders of Liquidia Technologies include Sapient Capital LLC (0.08%), Whitcomb & Hess Inc. (0.03%), Voya Investment Management LLC (0.01%) and Wedmont Private Capital (0.01%). Insiders that own company stock include Caligan Partners Lp, Roger Jeffs, Russell Schundler, Paul B Manning, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Dana Boyle, Jason Adair, Scott Moomaw, Sarah Krepp and Raman Singh.
View institutional ownership trends
.

Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia Technologies investors own include JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Ford Motor (F), Predictive Oncology (POAI), Tesla (TSLA), Advanced Micro Devices (AMD) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/12/2025
Today
10/17/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LQDA
CIK
1819576
Fax
N/A
Employees
50
Year Founded
2004

Price Target and Rating

High Price Target
$43.00
Low Price Target
$13.00
Potential Upside/Downside
+44.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$130.39 million
Net Margins
-732.17%
Pretax Margin
-784.54%
Return on Equity
-232.96%
Return on Assets
-60.81%

Debt

Debt-to-Equity Ratio
9.84
Current Ratio
2.49
Quick Ratio
2.41

Sales & Book Value

Annual Sales
$14 million
Price / Sales
138.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.91 per share
Price / Book
24.70

Miscellaneous

Outstanding Shares
86,090,000
Free Float
63,277,000
Market Cap
$1.94 billion
Optionable
Optionable
Beta
0.15

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:LQDA) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners